VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo

Published on 20 Dec 2024 on Zacks · via Yahoo Finance

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor,...

Read the rest of the article

Start tracking your investments with Statfolio

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shareholders might be concerned after seeing th...

Simply Wall St. · via Yahoo Finance 31 Dec 2024

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In...

Insider Monkey · via Yahoo Finance 25 Dec 2024

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 24 Dec 2024

On Monday, Truist Securities adjusted its price target for Vertex Pharmaceuticals (NASDAQ:VRTX)...

Investing.com 23 Dec 2024

The FDA's nod is based on late-stage data, which show that treatment with VRTX's Alyftrek enhance...

Zacks · via Yahoo Finance 23 Dec 2024

We recently compiled a list of the Jim Cramer Talked About These 17 Stocks After The Fed’s Rate C...

Insider Monkey · via Yahoo Finance 23 Dec 2024

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor,...

Zacks · via Yahoo Finance 20 Dec 2024

On Thursday, BofA Securities adjusted its outlook on Vertex Pharmaceuticals (NASDAQ:VRTX), reduci...

Investing.com 19 Dec 2024

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnsto...

Insider Monkey · via Yahoo Finance 19 Dec 2024

On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2...

Benzinga · via Yahoo Finance 19 Dec 2024